Nanomedicine News

RSS

Rexahn Announces Promising Preclinical Results for RX-21101 Nano-Polymer Conjugate of Docetaxel

Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced promising preclinical results for RX-21101, the Company’s first development candidate derived from its Nano-Polymer-Drug Conjugate System (NPDCS) platform.

22 Apr 2014

Micromem Commences Manufacturing of Nanoparticle Detection Platform

Micromem Technologies Inc. (the "Company") through its wholly owned subsidiary Micromem Applied Sensor Technologies Inc. (MAST), announces manufacturing has begun for client orders of our nanoparticle detection platform (the "Detector").

From Micromem Technologies Inc. 22 Apr 2014

Aqueous Nanoparticle Solution Repairs Deep Wounds

A significant breakthrough could revolutionize surgical practice and regenerative medicine. A team led by Ludwik Leibler from the Laboratoire Matière Molle et Chimie (CNRS/ESPCI Paris Tech) and Didier Letourneur from the Laboratoire Recherche Vasculaire Translationnelle (INSERM/Universités Paris Diderot and Paris 13), has just demonstrated that the principle of adhesion by aqueous solutions of nanoparticles can be used in vivo to repair soft-tissue organs and tissues.

21 Apr 2014

NanoSmart and NanoValent Partner to Develop ANA-Conjugated Liposomal Doxorubicin Nanoparticle for Cancer Treatment

NanoSmart® and NanoValent, private pharmaceutical companies developing novel cancer pharmaceuticals, have entered into a research collaboration agreement to explore the feasibility of jointly developing an ANA-conjugated liposomal doxorubicin nanoparticle for the treatment of ovarian cancer and other solid tumors.

18 Apr 2014

Optical Camera Integrated with Nanoparticle Technology Provides Clear View of Cancer in the Body

With a new, commercially available camera system using Cornell-developed nanoparticles that make cancer cells glow, the way is lit for surgeons diagnosing and removing tumors.

18 Apr 2014

Crystallographic Techniques Help Understand Effects of Medical Treatment for Nanocrystal Cystine Kidney Stones

Researchers in France have hit on a novel method to help kidney stone sufferers ensure they receive the correct and most effective treatment possible.

18 Apr 2014

Nanoparticle Delivery Boosts Capacity of Double-Stapled Peptides to Block RSV Infection

New therapies are needed to prevent and treat respiratory syncytial virus (RSV) – a potentially lethal respiratory infection that can severely affect infants, young children and the elderly.

18 Apr 2014

Forecast Report on Global Nanomedicine Market

Global Information Inc. announces the addition of a new market research report "Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019" at GIIResearch.com

18 Apr 2014

Cu-Cy Nanoparticles Exposed to X-rays Slow Tumor Growth

A University of Texas at Arlington physicist working to create a luminescent nanoparticle to use in security-related radiation detection may have instead happened upon an advance in photodynamic cancer therapy.

17 Apr 2014

NanoViricides Honored with IAIR Award for Leadership in Nanomedicine

NanoViricides, Inc. (the "Company") has won the prestigious “IAIR Award” as the “Best North American Company for Leadership in the Nanomedicine Sector.”

From NanoViricides, Inc 17 Apr 2014